The name on an online health website may not be the name of the pharmacy dispensing your medication. Before accepting a compounded NAD+ prescription, ask who will prepare it and how to contact that team directly.
Verification is a practical process, not a search for a reassuring badge. A license, facility registration, product test, and FDA drug approval each answer a different question. Keeping them separate helps you evaluate the information fairly.
Verify the dispensing facility and the preparation, not only the brand selling access to it.
Get the exact identity
Request the pharmacy’s legal name, physical location, telephone number, and license details. A corporate group may operate more than one facility, so confirm the specific location handling your prescription. Write down the prescriber’s details separately.
If support says the pharmacy is selected after approval, ask when its identity will be provided and whether you can review it before dispensing. Do not infer the pharmacy from a stock product image or another patient’s order.
Check the relevant regulator
Use the National Association of Boards of Pharmacy directory to find your state’s pharmacy regulator. Check the facility details against the regulator’s record and ask about any authorization required to ship into your state. A current license is relevant, but it does not prove every claim on a sales page.
For clinicians, the Federation of State Medical Boards directory can help locate the appropriate medical board. Other professions may have different regulators. Our location pages connect the geographic search with these verification resources.
Ask preparation-specific quality questions
FDA has warned about ingredients unsuitable for sterile compounding in NAD+ injectable products. Ask the pharmacy how it establishes ingredient suitability and what quality checks apply to the preparation dispensed to you.
Potency asks whether the preparation has the intended strength. Sterility and endotoxin controls address different contamination risks. A broad statement about laboratory testing is not the same as an explanation of the batch or process relevant to your vial.
Read the label before the first use
Confirm the patient name, drug, concentration, prescribed route, instructions, storage requirements, and beyond-use date. Ask the pharmacist about anything that does not match what the clinician told you. Keep the packaging and lot details for reference.
Our label-reading guide explains why milligrams, milliliters, and syringe markings must be connected by the prescription rather than guessed. Clear instructions should not require you to solve an unfamiliar calculation alone.
Know what to do when something is wrong
Ask how to handle a delayed or damaged shipment, an unclear label, or suspected temperature exposure. Do not use a questionable product until the pharmacist or clinician has assessed the situation. Photographing the package and keeping its details can help that discussion.
For symptoms after treatment, use the clinical escalation plan. Read the safety guide and ask for a direct contact route. A pharmacy review, such as our Olympia overview, should support these checks rather than replace them.
The Empower Pharmacy review illustrates how to read a current catalog alongside a historical FDA inspection record. Our Olympia review covers another supplier model. Neither pharmacy review establishes which facility a particular online clinic uses for your prescription.
For concrete supplier documents, read Hallandale, MediVera, Wells, AnazaoHealth, Belmar, FarmaKeio, and Westmoreland. They cover premixed and lyophilized products, multiple routes, patient inserts, and dated order forms. Verify the actual preparation and facility rather than treating the pharmacy name as a complete treatment plan.
Follow the source
References & further reading
- NABP — boards of pharmacy
Find the pharmacy regulator for your state.
- FSMB — state medical board directory
Find the appropriate state regulator and license lookup.
- FDA — ingredients suitable for sterile compounding
Reports NAD+ injectable adverse events and ingredient-quality concerns.
- FDA — compounding questions and answers
Compounded drugs are not FDA-approved or reviewed before marketing for safety, effectiveness, or quality.